Over the past year, we have carefully considered whether — and how — life sciences companies can use AI tools in their clinical development ...

A second Trump Administration might mean deregulation and more permitted transactions for the banking industry. Many, but not all, agency priorities may also change significantly. While the coming ...

An explanation of real-world asset (RWA) tokenization use cases and guidance on the tokenization process, including asset ...

Clinical trials are undergoing a fundamental shift as emerging technologies reshape how studies are designed, executed and ...

An explanation of the legal, regulatory, and operational frameworks for crypto-based exchange-traded funds (crypto ETFs) and ...

The Global Regulatory Brief provides monthly insights on the latest risk and regulatory developments. This brief was written by Bloomberg’s Regulatory Affairs Specialists. The Commodity Futures ...

What Businesses Should Know About Deconstruction Opportunities in the Coming Weeks St Louis, United States – February 7, 2026 / Deconstruction Development Partners / Valensi Rose PLC provides the ...

Welcome to the Journal of Regulatory Affairs, featuring in-depth coverage of the EU Artificial Intelligence Act (EU AI Act) as well as articles on engineering safety and effectiveness in drug-device ...

Franchise regulatory considerations cover a multitude of areas, including financial disclosures, registration of the Franchise Disclosure Document (FDD), franchisee rights, and adequate support and ...

This course provides a basic understanding of the challenges and goals confronting a regulatory professional when defining a global regulatory strategy. Understanding global demands from the ...